$1028.51▾ 0.31%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 497% above our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
argenx SE - American Depositary Shares's earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days2 articles
2 bullish0 neutral0 bearish
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline
argenx Completes Acquisition of Forte Biosciences, Inc.
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
argenx to Host Autoimmune Myositis R&D Webinar